Nontuberculous mycobacterial infections in patients with hematologic malignancies and recipients of hematopoietic stem cell transplantation

S El Zein, MA Mendoza… - Transplant Infectious …, 2023 - Wiley Online Library
Background The incidence of mycobacterial infections in patients with hematologic
malignancies and hematopoietic stem cell transplant (HSCT) recipients is increasing …

Prevention and management of infectious complications in patients with chronic leucocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current …

M Mikulska, C Oltolini, E Zappulo, M Bartoletti… - Blood Reviews, 2024 - Elsevier
CLL is associated with an increased risk of infectious complications. Treatment with BTK or
BCL-2 inhibitors does not seem to increase significantly the risk of opportunistic infections …

Disseminated nontuberculous mycobacterial infections after allogeneic hematopoietic stem cell transplantation: a risk-based strategy for early diagnosis

LGM Daenen, JT van der Bruggen, RJ Leguit… - Bone Marrow …, 2023 - nature.com
Nontuberculous mycobacteria (NTM) are ubiquitous environmental organisms and widely
distributed in water and soil [1]. In humans, NTM infections can be localized to the lungs, but …

[HTML][HTML] Case Report: Active tuberculosis infection in CAR T-cell recipients post CAR T-cell therapy: a retrospective case series

P Zhang, L Huang, M Zheng, C Zhang… - Frontiers in Cellular …, 2023 - frontiersin.org
Chimeric antigen receptor (CAR) T-cell therapy has yielded high response rates in B-cell
malignancies. Emerging reports demonstrate that the risk of active tuberculosis (TB) in the …

A multistage Sendai virus vaccine incorporating latency-associated antigens induces protection against acute and latent tuberculosis

Z Hu, J Xia, J Wu, H Zhao, P Ji, L Gu, W Gu… - Emerging Microbes & …, 2024 - Taylor & Francis
One-quarter of the world's population is infected with Mycobacterium tuberculosis (Mtb).
After initial exposure, more immune-competent persons develop asymptomatic latent …

Nontuberculous Mycobacterial Infections in Pediatric Solid Organ Transplant and Hematopoietic Cell Transplant Recipients

J Albert, CL Daley, PL Lin - Journal of the Pediatric Infectious …, 2024 - academic.oup.com
The diagnosis of nontuberculous mycobacterial infections is challenging in pediatric solid
organ transplant and hematopoietic cell transplant recipients due to the absence of specific …

Latent tuberculosis infection in haematopoietic stem cell transplant recipients: a retrospective Italian cohort study in Tor Vergata University Hospital, Rome

M Compagno, A Navarra, L Campogiani… - International Journal of …, 2022 - mdpi.com
The results of tuberculosis (TB) screening and reactivation in a cohort of 323 adult patients
undergoing haematopoietic stem cell transplantation (HSCT) from 2015 to 2019 at the …

Bacterial Pathogens Causing Pneumonia Post Hematopoietic Stem Cell Transplant: The Chronic GVHD Population

S Chaaban, A Zimmer, VR Bhatt, C Schmidt… - Pathogens, 2023 - mdpi.com
Allogeneic stem cell transplantation is a lifesaving treatment for many malignancies. Post-
transplant patients may suffer from graft versus host disease in the acute and/or the chronic …

A Retrospective Study of Factors Contributing to the Performance of an Interferon-Gamma Release Assay Blood Test for Tuberculosis Infection

J Song, S Kim, Y Park - Clinical Chemistry, 2024 - academic.oup.com
Background Tuberculosis (TB) remains a significant global health concern. Accurate
detection of latent TB infection is crucial for effective control and prevention. We aimed to …

Evaluation of pulmonary abnormalities in recipients of hematopoietic cell transplants and cellular therapies

L Thomas, J Boatman - Transplant Infectious Disease, 2023 - Wiley Online Library
Hematopoietic cell transplant (HCT) and chimeric antigen receptor T‐cell (CAR‐T) therapy
recipients are susceptible to multiple pulmonary complications that are caused by infectious …